Simon addressed the audience highlighting the importance of providing reasonably priced, accurate, accessible, and easy to use solutions for the assessment and evaluation of people with suspected brain injury and other neurological and neuropsychiatric conditions. Cerora's MindReader™ device allows healthcare practitioners, including certified athletic trainers, nurses, and other affiliated health care practitioners to quickly collect data on site which is then transmitted wirelessly using Cerora software for rapid, remote evaluation by physicians and clinical psychologists.
Simon stressed "Cerora's value proposition is the ability to move the urgent follow-up to a suspected brain injury from a highly subjective clinical impression to rapid and objective biosensor-based measurements in an accurate, accessible format that is easy to use by field clinicians." Simon presented company concussion data discussed at an international Traumatic Brain Injury conference earlier this year.
Technology Also Shows Promise in Diagnosis of Alzheimer's / Other Neurologic Conditions
Simon also discussed Cerora's recently published peer reviewed paper (
Commenting on the diverse applications for Cerora's technology, David M Devilbiss, PhD, Cerora's Head of Research and Development stated that "Cerora's technology platform of neurophysiological and neuropsychological test batteries has been designed to be portable, user friendly, and sensitive to changes in brain function. The approach has broad applicability ranging from detecting acute changes such as mild traumatic brain injury (concussion) to developmental disorders such as Autism to neurological diseases including Alzheimer's disease."
This pilot clinical study was led by
Dr. Bernstein expressed, "the non-invasive MindReader™ technology made it easy to gather data from patients in an outpatient setting and was readily accepted by dementia participants. It makes it easier to develop a biomarker for patients with varying degrees of cognitive impairment." Dr. Bernstein added that the preliminary data suggests that more detailed studies should be initiated on larger populations including other potential pathologies of cognitive impairment.
About Traumatic Brain Injury (TBI)
TBI often referred to as concussion is due to mechanical forces causing brain injury. It affects toddlers, athletes, traffic accident victims, military warfighters, and seniors to name a few. Incidence estimates range from 1.7 million to 3.8 million per year in
About Alzheimer's disease (AD)
Alzheimer's disease (AD) is a chronic neurodegenerative disorder affecting millions of people worldwide. It is the number one form of dementia in the world. Dementia, a loss of mental function affecting memory, cognition, speech etc., has a variety of causes and is believed to reflect underlying dysfunction of brain cells. The risk of being afflicted with AD increases with age, with one in nine people over the age of 65 having the disease. Please refer to the Alzheimer's Association Facts and Figures (2).
(1) Ghorbanian, P. et al. Identification of Resting and Active State EEG Features of Alzheimer's Disease using Discrete Wavelet Transform. Ann Biomed Eng 41(6):1243-1257,
Jim Sullivan+1 (510) 517-5982 firstname.lastname@example.org